Zhengye Biotechnology Holding Ltd
Business
Zhengye Biotechnology Holding Ltd develops, manufactures and sells veterinary vaccines, focusing on research and production for livestock health. Its main products include a portfolio of 46 veterinary vaccines covering swine, poultry, cattle, goats, sheep and dogs, plus R&D into household pet and mRNA vaccines. The company operates through its consolidated operating entity with R&D, production, quality control and sales functions, and engages in technology licensing and cooperative research with universities and institutes. Its products are sold across 28 Chinese provincial regions and exported via domestic and exporting distributors to countries including Vietnam, Pakistan and Egypt, using direct sales, distributor networks and government procurement channels.
Summary from filing dated 2025-07-03
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | $16.64M |
| Net income | $-9.98M |
| Total assets | $62.41M |
| Total liabilities | $18.56M |
| Stockholders' equity | $35.72M |
| Operating cash flow | $1.91M |